Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV vaccine.

作者: Newton Wahome , Tanya Pfeiffer , Ina Ambiel , Yongkun Yang , Oliver T. Keppler

DOI: 10.1111/J.1747-0285.2012.01423.X

关键词:

摘要: The self-assembling protein nanoparticle (SAPN) is an antigen-presenting system that has been shown to be suitable for use as a vaccine platform. SAPN scaffold based on the principles of icosahedral symmetry, beginning from monomeric chain self-assembles into ordered oligomeric state. contains two covalently linked α-helical coiled-coil domains, N-terminal de novo-designed pentameric tryptophan zipper and C-terminal trimeric leucine zipper, which assemble along internal symmetry axes icosahedron. In this study, we incorporated membrane proximal external region (MPER) HIV-1 gp41 HXB2 pentamer, referred MPER-SAPN, attempting reproduce state 4E10 epitope while maintaining structurally less-constrained 2F5 epitope. Sprague-Dawley rats were immunized with MPER-SAPNs, their sera analyzed induced humoral anti-HIV-1 responses. We show high region-specific titers can raised via repetitive antigen display MPER without need adjuvant. However, none displayed detectable neutralizing activity against HIV-1. Thus, 4E10- 2F5-like antibodies could not elicited by conformationally restrained in context.

参考文章(40)
Susan Zolla-Pazner, Improving on nature: focusing the immune response on the V3 loop. Human antibodies. ,vol. 14, pp. 69- 72 ,(2006) , 10.3233/HAB-2005-143-403
G. Frey, H. Peng, S. Rits-Volloch, M. Morelli, Y. Cheng, B. Chen, A fusion-intermediate state of hiv-1 gp41 targeted by broadly neutralizing antibodies Proceedings of the National Academy of Sciences of the United States of America. ,vol. 105, pp. 3739- 3744 ,(2009) , 10.1073/PNAS.0800255105
Javier Guenaga, Pia Dosenovic, Gilad Ofek, David Baker, William R. Schief, Peter D. Kwong, Gunilla B. Karlsson Hedestam, Richard T. Wyatt, Heterologous Epitope-Scaffold Prime∶Boosting Immuno-Focuses B Cell Responses to the HIV-1 gp41 2F5 Neutralization Determinant PLoS ONE. ,vol. 6, pp. e16074- ,(2011) , 10.1371/JOURNAL.PONE.0016074
Laurent Verkoczy, M. Anthony Moody, T. Matt Holl, Hilary Bouton-Verville, Richard M. Scearce, Jennifer Hutchinson, S. Munir Alam, Garnett Kelsoe, Barton F. Haynes, Functional, Non-Clonal IgMa-Restricted B Cell Receptor Interactions with the HIV-1 Envelope gp41 Membrane Proximal External Region PLoS ONE. ,vol. 4, pp. e7215- ,(2009) , 10.1371/JOURNAL.PONE.0007215
Ulrich Schroeder, Alexandra Graff, Sabine Buchmeier, Per Rigler, Unai Silvan, David Tropel, Brigitte M. Jockusch, Ueli Aebi, Peter Burkhard, Cora-Ann Schoenenberger, Peptide nanoparticles serve as a powerful platform for the immunogenic display of poorly antigenic actin determinants. Journal of Molecular Biology. ,vol. 386, pp. 1368- 1381 ,(2009) , 10.1016/J.JMB.2008.11.023
Tais A. P. F. Pimentel, Zhe Yan, Scott A. Jeffers, Kathryn V. Holmes, Robert S. Hodges, Peter Burkhard, Peptide Nanoparticles as Novel Immunogens: Design and Analysis of a Prototypic Severe Acute Respiratory Syndrome Vaccine Chemical Biology & Drug Design. ,vol. 73, pp. 53- 61 ,(2009) , 10.1111/J.1747-0285.2008.00746.X
Valerie Bosch, Tanya Pfeiffer, Gerard Devitt, Ina Allespach, Thomas Ebensen, Vanessa Emerson, Carlos A. Guzman, Oliver T. Keppler, HIV pseudovirion vaccine exposing Env "fusion intermediates"-response to immunisation in human CD4/CCR5-transgenic rats. Vaccine. ,vol. 27, pp. 2202- 2212 ,(2009) , 10.1016/J.VACCINE.2009.02.014